Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 622 | Longs Won 331/621 53% | Profit Factor 1.85 |
| Profitability | Shorts Won 1/1 100% | Standard Deviation $4,749.74 |
| Average Win $2,243.97 | Best Trade (Feb 23) $65,138.63 | Sharpe Ratio -80.73 |
| Average Loss -$1,390.83 | Worst Trade (Nov 06) -$26,625.19 | Z-Score -6.38 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1w 1d | Expectancy $549.29 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.05% | 0.84% | 10.49% |
| Consecutive Losing Trades | 318 | 286 | 254 | 222 | 191 | 159 | 127 | 95 | 64 | 32 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
LONA Athira Pharma Inc. | 57,469.9 | $449,989.3 | $441,656.16 | - | -$8,333.14 | -1.85% | -0.195% |